Indian News


june-june22.jpg Only a week left in the quarter, and the week that passed by saw some of the DMD drug stocks make headlines. Now, here are some of the pharma/biotech stocks and upcoming events to keep an ear out for in the coming week.

pharma-june21.jpg The following are some of the stocks that gained the largest percentage in price today in the pharma/biotech sector.

sangamobuilding-june21.jpg Shares of Sangamo Therapeutics Inc. (SGMO) are down nearly 33% from their 52-week high to $18. Given the fact that the Company has potential clinical data readouts from 7 studies beginning in late summer of this year to 2019, it is worth keeping an eye on this stock.

pharma-042318.jpg Today's Daily Dose brings you news about Atossa's progress in phase I study of its proprietary topical Endoxifen in men; the three biopharmaceutical companies that are set to debut on the Nasdaq on June 21, 2018; Kindred Biosciences' financial position; FDA panel review date of Paratek's Omadacycline NDA, and STAAR Surgical's resolution of FDA warning letter.

pharma-june19.jpg The following are some of today's top gainers in the pharma/biotech sector.

pharma-daily-060618.jpg Today's Daily Dose brings you news about Alexion's progress in paroxysmal nocturnal hemoglobinuria; Anika's disappointing results of CINGAL in osteoarthritis of the knee; timeline of Kala's submission of New Drug Application for KPI-121 0.25% for the treatment of dry eye disease; Marinus' Marigold study and Pacira's deal with China-based Nuance Biotech.

Follow RTT